MedPath

Quality of Life After Conformal Radiotherapy in Late Stage Oral Cavity Cancer:A Prospective clinical Trial

Not Applicable
Completed
Conditions
Health Condition 1: null- Carcinoma Oral Cavity Stage IV A and IV B fit for palliative treatment
Registration Number
CTRI/2018/03/012441
Lead Sponsor
Jawaharlal Institue of Postgraduate Medical Education and research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
25
Inclusion Criteria

i)Biopsy proven Squamous cell carcinoma

ii)Surgically unresectable stage IVB oral cavity cancer where oral cavity is defined as consisting of lip, alveolus, floor of mouth, hard palate, retromolar trigone, buccal mucosa and tongue (extension to infratemporal fossa extension,masticator space, pterygoid plates, or skull bases or encases internal carotid artery )

iii)Stage IVA disease- not fit for surgery/ curative treatment

iv)Stage IVC disease-for palliation of local symptoms

v)No previous history of radiotherapy/chemotherapy/surgery

vi)No previous history of cancer

Exclusion Criteria

i)Patients with another primary at a different site

ii)Pregnant women

iii)Age <18 and >80 years

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess the effect of hypofractionated palliative radiotherapy on quality of life in patients with late stage oral cavity cancer with the EORTC H&N 35 questionnaire with specific attention to pain,swallowing and mouth opening sub scalesTimepoint: 2 months
Secondary Outcome Measures
NameTimeMethod
Compliance to the treatment regimenTimepoint: 6 months;Acute toxicity during radiation therapy â?? using RTOG/CTCAE grading.Timepoint: 2 months;Assessment of general quality of life as per the QLQ C30 and other parameters in the H&N 35Timepoint: 2 months <br/ ><br>;Late toxicity using RTOG/CTCAE grading14Timepoint: 6 months;Median survivalTimepoint: 6 months;The response rates as assessed by the RECIST guidelines 1.1-complete, partial, overall response ratesTimepoint: 2 months <br/ ><br>
© Copyright 2025. All Rights Reserved by MedPath